Related Experiment Video

Updated: Jun 20, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Immunotherapy for cancer: synthetic carbohydrate-based vaccines

Therese Buskas1, Pamela Thompson, Geert-Jan Boons

  • 1Complex Carbohydrate Research Center, University of Georgia, 315 Riverbend Road, Athens, GA 30602, USA.

Chemical Communications (Cambridge, England)
|September 3, 2009
PubMed

Insights

Fully synthetic cancer vaccines targeting aberrant glycosylation show promise for immunotherapy. These well-defined carbohydrate-based vaccines may overcome limitations of traditional approaches for improved cancer treatment.

Area of Science:

  • Oncology
  • Immunology
  • Carbohydrate Chemistry

Background:

  • Aberrant glycosylation in cancer cells correlates with poor prognosis.
  • Glycosylation changes are key targets for cancer immunotherapy development.

Purpose of the Study:

  • To discuss recent advances in fully synthetic, carbohydrate-based cancer vaccines.
  • To highlight the potential of these vaccines in cancer immunotherapy.

Main Methods:

  • Leveraging knowledge of innate and adaptive immune system cooperation.
  • Utilizing efficient synthetic methods for oligosaccharide and glycopeptide assembly.
  • Developing fully synthetic vaccine candidates incorporating essential immune-response elements.

Main Results:

  • Fully synthetic vaccines offer a chemically defined and reproducible approach.
  • These vaccines avoid immune suppression associated with classical conjugate vaccines.
  • They incorporate specific elements required for relevant immune responses.

Conclusions:

  • Fully synthetic carbohydrate-based vaccines represent a promising strategy for cancer immunotherapy.
  • These novel vaccines have the potential to overcome limitations of existing therapies.
  • Further development in this area could lead to more effective cancer treatments.

More Related Videos

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...